Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol
Regulating blood cholesterol (Chol) levels by pharmacotherapy has successfully improved cardiovascular health. There is growing interest in the role of Chol precursors in the treatment of diseases. One sterol precursor, desmosterol (Des), is a potential pharmacological target for inflammatory and ne...
Main Authors: | Phillip A. Wages, Hye-Young H. Kim, Zeljka Korade, Ned A. Porter |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-10-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520341833 |
Similar Items
-
Vulnerability of DHCR7+/− mutation carriers to aripiprazole and trazodone exposure
by: Zeljka Korade, et al.
Published: (2017-11-01) -
Effect of long-term administration of AY-9944, an inhibitor of 7-dehydrocholesterol Δ7-reductase, on serum and tissue lipids in the rat
by: D. Dvornik, et al.
Published: (1968-09-01) -
Effects of Psychotropic Medication on Somatic Sterol Biosynthesis of Adult Mice
by: Marta Balog, et al.
Published: (2022-10-01) -
Engineering of <i>Saccharomyces cerevisiae</i> for 24-Methylene-Cholesterol Production
by: Jiao Yang, et al.
Published: (2021-11-01) -
Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7α-hydroxylase and 27-hydroxylase activities in rat liver
by: Akira Honda, et al.
Published: (1999-08-01)